Mesalamine and Prilosec otc drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mesalamine (mesalamine) and Prilosec otc (omeprazole magnesium). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Mesalamine and Prilosec otc. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.

What is Prilosec otc?

Prilosec otc has active ingredients of omeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 38,394 Prilosec otc users. Check the latest studies of Prilosec otc.



On Jul, 07, 2026

22 people who take Mesalamine and Prilosec otc together, and have interactions are studied.

Mesalamine and Prilosec otc drug interactions.

What are the common drug interactions of Mesalamine and Prilosec Otc, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Drug ineffective
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
  9. Gastric cancer (stomach cancer)
  10. Pelvic abscess

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Headache (pain in head)
  4. Nausea (feeling of having an urge to vomit)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal injury (kidney injury)
  7. Balance disorder
  8. Dizziness
  9. Drug ineffective
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Mesalamine and Prilosec Otc, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal injury (kidney injury)

50-59:

  1. Hyperkalaemia (damage to or disease of the kidney)
  2. Balance disorder
  3. Dizziness
  4. Drug ineffective
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Dysstasia (difficulty in standing)
  8. Fungal infection
  9. Gastric disorder (disease of stomach)
  10. Headache (pain in head)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)

What are the existing conditions these people have? *

  1. Pain: 10 people, 45.45%
  2. High Blood Pressure: 9 people, 40.91%
  3. High Blood Cholesterol: 8 people, 36.36%
  4. Infection: 6 people, 27.27%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 22.73%
  6. Stress And Anxiety: 5 people, 22.73%
  7. Blood Pressure Abnormal: 5 people, 22.73%
  8. Diabetes: 5 people, 22.73%
  9. Gout (uric acid crystals building up in the body): 4 people, 18.18%
  10. Multiple Allergies (allergy to multiple agents): 4 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Mesalamine and Prilosec otc?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mesalamine and Prilosec otc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prilosec otc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesalamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prilosec otc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and omeprazole magnesium (the active ingredients of Mesalamine and Prilosec otc, respectively), and Mesalamine and Prilosec otc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: